Prospective study of serum micronutrients and ovarian cancer

Journal of the National Cancer Institute

Volumn 88, Issue 1, 1996, Pages 32-37

  Helzlsouer, Kathy J ^a   Alberg, Anthony J ^a   Norkus, Edward P ^b   Morris, J Steven ^c   Hoffman, Sandra C ^a   Comstock, George W ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b OUR LADY OF MERCY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CHOLESTEROL; CRYPTOXANTHIN; FREE RADICAL; GAMMA TOCOPHEROL; LYCOPENE; RETINOL; SELENIUM; XANTHOPHYLL;

ADULT; ARTICLE; BLOOD LEVEL; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUTRON ACTIVATION ANALYSIS; NUTRIENT; OVARY CANCER; PROSPECTIVE STUDY; REGRESSION ANALYSIS;

CAROTENOIDS; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HUMANS; MICRONUTRIENTS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; SELENIUM; VITAMIN A; VITAMIN E;

EID: 0030053053     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.1.32     Document Type: Article

References (36)

1. Harman D. Free radicals and the origination, evolution, and present status of the free radical theory of aging. In: Armstrong D, Sohal RS, Cutler RG, Slater TF, editors. Free radicals in molecular biology, aging, and disease. Vol 27, Aging. New York: Raven Press, 1984:1-12.
2. Gower JD. A role for dietary lipids and antioxidants in the activation of carcinogens. Free Radic Biol Med 1988;5:95-111.
3. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, et al. Oxygen radicals and human disease [clinical conference]. Ann Intern Med 1987;107:526-45.
4. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991;53(1 Suppl):189S-93S.
5. Wattenberg LW. Inhibition of chemical carcinogens by minor dietary components. In: Arnott MS, van Eys J, Wang YM, editors. Molecular interrelations of nutrition and cancer. New York: Raven Press, 1982:43-56.
6. Anderson R. Assessment of the roles of vitamin C, vitamin E, and β-carotene in the modulation of oxidant stress mediated by cigarette smoke-activated phagocytes. Am J Clin Nutr 1991;53(1 Suppl):358S-61S.
7. Knekt P. Serum vitamin E level and risk of female cancers. Int J Epidemiol 1988;17:281-6.
8. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Hakama M, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-8.
9. Hiatt RA, Fireman BH. Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 1986;39:861-70.
10. Sundstrom H, Yrjanheikki E, Kauppila A. Serum selenium in patients with ovarian cancer during and after therapy. Carcinogenesis 1984;5:731-4.
11. Sundstrom H, Ylikorkala O, Kauppila A. Serum selenium and thromboxane in patients with gynaecological cancer. Carcinogenesis 1986; 7:1051-2.
12. Drozdz M, Tomala J, Jendryczko A, Banas K. Concentration of selenium and vitamin E in the serum of women with malignant genital neoplasms and their family members. Ginekol Pol 1989;60:301-5.
13. Heinonen PK, Kuoppala T, Koskinen T, Punnonen R. Serum vitamins A and E and carotene in patients with gynecologic cancer. Arch Gynecol Obstet 1987;241:151-6.
14. Slattery ML, Schuman KL, West DW, French TK, Robison LM. Nutrient intake and ovarian cancer. Am J Epidemiol 1989;130:497-502.
15. Byers T, Marshall J, Graham S, Mettlin C, Swanson M. A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 1983;71:681-6.
16. La Vecchia C, Decarli A, Negri E, Parazzini F, Gentile A, Cecchetti G, et al. Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst 1987;79:663-9.
17. Engle A, Muscat JE, Harris RE. Nutritional risk factors and ovarian cancer. Nutr Cancer 1991;15:239-47.
18. Risch HA, Jain M, Marrett LD, Howe GR. Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 1994;86:1409-15.
19. Cramer DW, Welch WR, Hutchison GB, Willett W, Scully RE. Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 1984;63:833-8.
20. Comstock GW, Bush TL, Helzlsouer KJ. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-21.
21. 1987 Annual Cancer Statistics Review. National Cancer Institute. NIH Publ No. 88-2789. Bethesda (MD): Public Health Service, National Institutes of Health, 1988.
22. Aftergood L, Alexander AR, Alfin-Slater RB. Effect of oral contraceptives on plasma lipoproteins, cholesterol and α-tocopherol levels in young women. Nutr Rep Int 1975;11:295-304.
23. Comstock GW, Alberg AJ, Helzlsouer KJ. Reported effects of long-term freezer storage on concentrations of retinol, zβ-carotene, and α-tocopherol in serum or plasma summarized. Clin Chem 1993;39:1075-8.
24. Comstock GW, Norkus EP, Hoffman SC, Xu MW, Helzlsouer KJ. Stability of ascorbic acid, carotenoids, retinol, and tocopherols in plasma stored at -70 °C for 4 years. Cancer Epidemiol Biomarkers Prev 1995; 4:505-7.
25. Sowell AL, Huff DL, Yeager PR, Caudill SP, Gunter EW. Retinol, α-tocopherol, lutein/zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, trans-β-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection. Clin Chem 1994;40:411-6.
26. McKown DM, Morris JS. Rapid measurement of selenium in biologic samples using instrumental neutron activation analyses. J Radioanal Chem 1978;43:411-20.
27. Breslow NE, Day NE. Conditional logistic regression for matched sets. In: Davis W, Breslow NE, Day NE, editors. Statistical methods in cancer research, the analysis of case control studies. Vol I. Lyon: International Agency for Research on Cancer, 1980:248-79.
28. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
29. Behrens WA, Thompson JN, Madere R. Distribution of α-tocopherol in human plasma lipoproteins. Am J Clin Nutr 1982;35:691-6.
30. Ip C, Lisk DJ, Scimeca JA. Potential of food modification in cancer prevention. Cancer Res 1994;54(7 Suppl): 1957s-9s.
31. Biersack HJ, Grunwald F. Endocrinological applications in nuclear medicine. Semin Nucl Med 1995;25:92-110.
32. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK, et al. Prospective study of toenail selenium levels and cancer among women [see comment citation in Medline]. J Natl Cancer Inst 1995; 87:497-505.
33. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period [published erratum appears in Cancer Epidemiol Biomarkers Prev 1994;3:523]. Cancer Epidemiol Biomarkers Prev 1993;2:493-7.
34. Longnecker MP, Taylor RP, Levander OA, Howe SM, Veillon C, McAdam PA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr 1991;53:1288-94.
35. Dawber TR. The Framingham study, the epidemiology of atherosclerotic disease. Cambridge (MA): Harvard Univ Press, 1980:91-120.
36. Johnson BF. Intervention for control of hypertension. In: Ockene IS, Ockene JK, editors. Prevention of coronary heart disease. Boston: Little, Brown and Co., 1992:359-81.